NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
45 hedge funds and large institutions have $8.92M invested in Nymox Pharmaceutical Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
45
Holding in Top 10
–
Calls
$90K
Puts
$112K
Top Buyers
| 1 | +$37.1K | |
| 2 | +$35K | |
| 3 | +$32.5K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$30.2K |
| 5 |
Goldman Sachs
New York
|
+$29.7K |
Top Sellers
| 1 | -$233K | |
| 2 | -$126K | |
| 3 | -$61.8K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$49K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$46.5K |